Anticoagulant Reversal Drugs Market Scope And Analysis

  • Report Code : TIPRE00004954
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Anticoagulant Reversal Drugs Market - Scope by 2031

Buy Now

Anticoagulant Reversal Drugs Market Report Anticoagulant Reversal Drugs Market Size and Share Anticoagulant Reversal Drugs Market Scope and Analysis

Anticoagulant Reversal Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1306.40 Million
Market Size by 2031 US$ 2,442.87 Million
Global CAGR (2023 - 2031) 10.08%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa
By Product
  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Sanofi
  • Johnson Johnson
  • Glaxosmithkline
  • Bausch Health
  • Takeda Pharmaceuticals
  • Lexicon Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • AbbVie Inc